China Precision Medicine Market Share

Statistics for the 2023 & 2024 China Precision Medicine market share, created by Mordor Intelligence™ Industry Reports. China Precision Medicine share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of China Precision Medicine Industry

The market for precision medicine in China is moderately consolidated with the presence of several companies in the country. These companies work both globally and locally in the precision medicine market. Some of the companies are F Hoffmann-La Roche AG, New Horizon Health Ltd, Amoy Diagnostics, Berry Genomics, and Zhongyuan Union Stem Cell Bioengineering.

China Precision Medicine Market Leaders

  1. F Hoffmann-La Roche AG

  2. Zhongyuan Union Stem Cell Bioengineering

  3. Amoy Diagnostics

  4. New Horizon Health Ltd

  5. Berry Genomics

*Disclaimer: Major Players sorted in no particular order

China Precision Medicine Market Concentration

China Precision Medicine Market Size & Share Analysis - Growth Trends and Forecasts (2024 - 2029)